XML 62 R43.htm IDEA: XBRL DOCUMENT v3.25.2
Share Capital and Other Components of Equity (Tables)
12 Months Ended
Jun. 30, 2025
Share Capital and Other Components of Equity [Abstract]  
Schedule of Changes in the Fair Value of the Warrant Liability Level 3 Roll Forward

A summary of the changes in the fair value of the warrant liability Level 3 roll forward was as follows:

 

Warrants classified as liability  Number of
warrants
    Amount 
       $ 
Balance, July 1, 2024   
-
   $
-
 
Issuance of warrants in the units   1,015,200    15,689,207 
Issuance of overallotment warrants   152,280    2,334,346 
Converted to common shares   (1,167,461)   (18,023,263)
Balance, June 30, 2025   19   $290 

 

Warrants classified as mezzanine equity  Number of
warrants
   Amount 
       $ 
Balance, July 1, 2024   
-
   $
-
 
Issuance of underwriters’ warrants   50,760    784,000 
Converted to common shares   (50,760)   (784,000)
Balance, June 30, 2025   
-
   $
-
 
Schedule of Changes in the Company’s Stock Options

A summary of the changes in the Company’s stock options is as follows:

 

   June 30, 2025   June 30, 2024 
   Options (#)   Weighted average exercise price   Options (#)   Weighted average exercise price 
Outstanding, beginning of year   15,586   $421    17,076   $406 
Expired/cancelled   (9,805)   493    (817)   356 
Exercised   
-
    
-
    (673)   108 
Outstanding, end of year   5,781    187    15,586    421 
Exercisable, end of year   5,677    161    15,172    344 
Weighted average fair value at grant date of options granted   n/a         n/a      
Total intrinsic value of options exercised  $
-
        $1,020,473      
Total intrinsic value of options outstanding  $
-
        $30,563,749      
Total intrinsic value of options exercisable  $
-
        $30,135,740      
Schedule of Stock Options Outstanding

Details of stock options outstanding at June 30, 2025 were as follows:

 

Exercise price   Weighted
average
contractual
life
   Number of
options
outstanding
   Number of
options
exercisable
 
              
$71    0.46    4,412    4,412 
$119    1.87    868    868 
$154    2.71    94    94 
$1,591    7.21    407    303 
           5,781    5,677 
Schedule of Company Recognized Stock-Based Compensation Expense

During the year ended June 30, 2025, the Company recognized stock-based compensation expense of $63,539 (2024 – $146,841).

 

Stock-based compensation expense recorded in  June 30, 2025   June 30, 2024 
General and administrative expenses  $9,138   $58,765 
Research and development expenses   48,706    72,605 
Sales and marketing expenses   5,695    15,471 
   $63,539   $146,841 
Schedule of Warrants

Warrants of the Company classified as equity are composed of the following as at June 30, 2025:

 

Date of issuance  Number of
warrants
outstanding
   Number of
warrants
exercisable
   Exercise
price
   Expiry date
June 16, 2023   2,664    2,664    976   June 15, 2028
August 10, 2023   1,091    1,091    976   August 9, 2028
September 13, 2023   1,086    1,086    976   September 12, 2028
September 26, 2023   2,882    2,882    976   September 25, 2028
September 30, 2023   204    204    976   September 29, 2028
October 26, 2023   4,556    4,556    976   October 25, 2028
December 15, 2023   372    372    976   December 14, 2028
April 5, 2024   324    324    976   April 4, 2029
April 26, 2024   159    159    976   April 25, 2029
March 12, 2024   794    794    976   March 11, 2029
March 26, 2024   90    90    976   March 25, 2029
April 15, 2024   1,537    1,537    976   April 14, 2029
May 1, 2024   78    78    976   April 30, 2029
May 29, 2024   20    20    976   May 28, 2029
July 20, 2024   256    256    976   July 19, 2029
July 22, 2024   102    102    976   July 21, 2029
July 30, 2024   20    20    976   July 29, 2029
August 30, 2024   189    189    976   August 29, 2029
October 8, 2024   512    512    976   October 7, 2029
October 18, 2024   51    51    976   October 17, 2029
November 12, 2024   499    499    976   November 11, 2029
    17,486    17,486